Who is sponsoring NCT04595539?

NCT04595539 is sponsored by University of Liege.

What drugs are being tested in NCT04595539?

Interventions in NCT04595539: Behavioral Activation treatment with Attention Training Technique.

What condition does NCT04595539 study?

NCT04595539 studies Depression, Anxiety.

Is NCT04595539 still recruiting?

NCT04595539 is currently status unknown. Last updated 10 March 2021.

Last reviewed 2021-03-10 · How we verify

NCT04595539

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intervention Targeting Depressive Symptoms and Mental Rumination

Status unknown NA Last updated 10 March 2021

What this trial tests

NA trial testing Behavioral Activation treatment with Attention Training Technique in Depression, Anxiety in 13 participants. Status unknown.

Timeline

20 October 2020

Primary endpoint
30 April 2021

30 April 2021

Quick facts

Lead sponsor	University of Liege
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	13
Start date	20 October 2020
Primary completion	30 April 2021
Estimated completion	30 April 2021
Sites	1 location across Belgium

Drugs / interventions tested

Behavioral Activation treatment with Attention Training Technique

Conditions studied

Depression, Anxiety — all drugs for Depression, Anxiety →

Sponsor

University of Liege

Who can join

Adults 18 to 65, any sex, with Depression, Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the combine effects of Behavioral Activation and Attention Training on depression, well-being and other processes involved in depression as rumination. A multiple baseline design is followed with multiple idiographic assessments, in addition to a pre-post and follow-up standardized assessment design.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Is the combination of behavioral activation and attention training technique effective to reduce depressive symptomatology? A multiple case study.
Krings A, Geurten M, Lazari E, Blairy S. · · 2022 · cited 2× · PMID 35936312 · DOI 10.3389/fpsyg.2022.914094

Verify or expand the search:

Other recruiting trials for Depression, Anxiety

Currently open trials in the same condition.

NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
NCT07280481 — Weekly Dynamics of Psychopathological and Symptom Networks During Mindfulness-Based Interventions for Emotional Distress · NA · recruiting
NCT07014852 — Integrating Inuit Knowledge Principles in Multi-Level Mental Health Clinical Trials · EARLY_PHASE1 · recruiting
NCT07186816 — SUpport From PEeRs to Expand Access Study - Community · NA · recruiting
NCT07091032 — Building Connections · NA · recruiting

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04595539 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 10 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04595539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing